A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin. [electronic resource]
Producer: 20101130Description: 1593-601 p. digitalISSN:- 1528-0012
- Antiviral Agents -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Carriers
- Drug Therapy, Combination
- Follow-Up Studies
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Polyethylene Glycols -- administration & dosage
- RNA, Viral -- analysis
- Recombinant Proteins
- Retrospective Studies
- Ribavirin -- administration & dosage
- Time Factors
- Treatment Outcome
- Viral Load -- drug effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.